The Uncomfortable Truth: Open Thoracotomy versus Minimally Invasive Surgery in Lung Cancer: A Systematic Review and Meta-Analysis.
Dohun KimWon-Gi WooYoun Ho ShinSung Soo LeePublished in: Cancers (2023)
For decades, lung surgery in thoracic cancer has evolved in two ways: saving more parenchyma and being minimally invasive. Saving parenchyma is a fundamental principle of surgery. However, minimally invasive surgery (MIS) is a matter of approach, so it has to do with advances in surgical techniques and tools. For example, MIS has become possible with the introduction of VATS (video-assisted thoracic surgery), and the development of tools has extended the indication of MIS. Especially, RATS (robot-assisted thoracic surgery) improved the quality of life for patients and the ergonomics of doctors. However, the dichotomous idea that the MIS is new and right but the open thoracotomy is old and useless may be inappropriate. In fact, MIS is exactly the same as a classic thoracotomy in that it removes the mass/parenchyma containing cancer and mediastinal lymph nodes. Therefore, in this study, we compare randomized-controlled trials about open thoracotomy and MIS to find out which surgical method is more helpful.
Keyphrases
- minimally invasive
- thoracic surgery
- robot assisted
- lymph node
- papillary thyroid
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- aortic valve replacement
- squamous cell
- clinical trial
- peritoneal dialysis
- heart failure
- prognostic factors
- acute coronary syndrome
- coronary artery disease
- lymph node metastasis
- patient reported
- systematic review
- atrial fibrillation
- sentinel lymph node